APA (7th ed.) Citation

Kim, S., Jung, M., Kim, H., Byun, J. M., Hong, J., Shin, D., . . . Koh, Y. (2025). MG4101, an allogeneic natural killer cell, in patients with relapsed or refractory acute myeloid leukemia: A pilot study. Leukemia & Lymphoma, 66(2), 298. https://doi.org/10.1080/10428194.2024.2414903

Chicago Style (17th ed.) Citation

Kim, Sang-A, et al. "MG4101, an Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia: A Pilot Study." Leukemia & Lymphoma 66, no. 2 (2025): 298. https://doi.org/10.1080/10428194.2024.2414903.

MLA (9th ed.) Citation

Kim, Sang-A, et al. "MG4101, an Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia: A Pilot Study." Leukemia & Lymphoma, vol. 66, no. 2, 2025, p. 298, https://doi.org/10.1080/10428194.2024.2414903.